aDivision of General Medicine, Columbia University Medical Center, Center for Behavioral Cardiovascular Health
bDepartment of Psychiatry and Behavioral Science, State University of New York at Stony Brook, New York, USA
cDepartment of Cardiovascular Diseases, R. Silvestrini, Hospital, St. Andrea delle Fratte, Perugia PG
dInstitute of Medical Pathology, Santissima, Annunziata Medical Centre, Chieti Scalo, Italy
eDepartment of Clinical Pharmacology and Therapeutics, Tohoku University, Sendai, Japan
fDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan
gSchool of Medicine, Flinders University, Adelaide, Australia
Correspondence to Dr Thomas G Pickering, MD, D Phil, Professor of Medicine, Director, Behavioral Cardiovascular Health and Hypertension Program, Columbia Presbyterian Medical Center, PH 9-946, 622 West 168th Street, New York 10032, USA
Tel: +212 342 4489; fax: +212 305 3172; e-mail: [email protected]
Received 27 March 2007 Accepted 28 March 2007